CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹308 Cr | ₹240 Cr | ₹17 Cr | ₹235 Cr | ₹1,690 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹308 Cr |
| Mar2024 | ₹240 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹235 Cr |
| Mar2021 | ₹1,690 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹308 Cr | 28.33 | |
| Mar2024 | ₹240 Cr | 1,272.47 | |
| Mar2023 | ₹17 Cr | -92.55 | |
| Mar2022 | ₹235 Cr | -86.10 | |
| Mar2021 | ₹1,690 Cr | - | |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,301.5 Cr | -1.2% | 5% | -30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.2% |
5% |
-30.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses